You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
邁克生物(300463.SZ)擬斥1.5億元設立項目公司 作為投建邁克生物IVD天府產業園項目實施主體
格隆匯 11-25 19:36

格隆匯11月25日丨邁克生物(300463.SZ)公佈,公司與成都天府國際生物城管理委員會於2019年11月25日簽署了投資合作協議,公司擬取得成都天府國際生物城(“國際生物城”)86畝用地,並在國際生物城出資1.5億元設立全資子公司四川邁克醫療科技有限公司(具體名稱以工商核定為準,“項目公司”),項目公司將作為投資建設邁克生物IVD天府產業園項目(“項目”)的實施主體。

四川邁克醫療科技有限公司(擬)生產經營範圍:醫療器械的研發、銷售(未取得相關行政許可(審批),不得開展經營活動);貨物及技術進出口;醫療技術推廣服務;計算機軟硬件開發、銷售;計算機、軟件及輔助設備、通訊設備(不含無線電廣播電視發射設備及地面衞星接受設備)銷售;醫療設備的技術服務;會議及展覽展示服務;(依法須經批准的項目,經相關部門批准後方可開展經營活動)。

此次對外投資設立全資子公司主要是負責邁克生物IVD天府產業園項目的順利開展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account